生大粉在诱导糖尿病的老鼠中的治疗效果
Ambreen Qadir1, Faiza Anwar1, Habib Ur Rehman1
1Department of Allied Health Sciences, The Superior University, Lahore, Rahim Yar Khan Campus, Pakistan.
Pakistan journal of pharmaceutical sciences
|June 1, 2024
概括
生和大补充剂显著改善了老鼠的2型糖尿病. 这些天然疗法降低了血糖,改善了关键健康标志物,表明糖尿病并发症风险降低.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 代谢障碍 代谢障碍 代谢障碍
- 营养科学 营养科学
背景情况:
- 2型糖尿病是一个全球性的健康问题,其特点是高血糖和胰岛素抵抗.
- 目前用于2型糖尿病的治疗方法可能会产生副作用和不同的疗效.
- 像生 (Zingiber officinale) 和大 (Allium sativum) 这样的天然化合物传统上用于各种健康益处.
研究的目的:
- 在2型糖尿病的小鼠模型中研究生和大的低血糖作用.
- 评估生和大单独或组合对关键代谢参数的影响.
- 评估这些天然补充剂在缓解糖尿病并发症方面的潜力.
主要方法:
- 四十五只雄性白色大鼠被诱导患有2型糖尿病,使用了链毒素.
- 鼠被分为五组:正常控制,糖尿病控制,生,大和生+大.
- 动物接受了两个月的生和/或大粉,治疗后分析了各种血液和组织标记物.
主要成果:
- 与糖尿病控制组相比,补充生和/或大显著降低了禁食血糖,糖化血红蛋白,总胆固醇和低密度脂蛋白水平.
- 血清胰岛素和高密度脂蛋白水平在治疗组显著增加.
- 所有治疗组的肝糖原水平显示在统计学上显著增加.
结论:
- 生和大粉在2型糖尿病大鼠中显示出显著的低血糖效应.
- 和大的联合使用可能为治疗2型糖尿病提供协同效益.
- 这些发现表明,生和大可能是管理2型糖尿病和减少相关并发症的有价值的辅助剂.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
181
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
181
Oral Hypoglycemic Agents: Biguanides and Glitazones
189
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
189


